Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034800 · ClinicalTrials.gov registry record
The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215
A clinical trial, sponsored by National Institute on Drug Abuse (NIDA).
- Completed
- Registry status
NCT01034800 is a clinical trial that has completed, run by National Institute on Drug Abuse (NIDA).
The verdict
NCT01034800 has completed, sponsored by National Institute on Drug Abuse (NIDA).
- COMPLETED
- Registry status
Study Summary
The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose of this study is to test the hypothesis that repetitive illicit drug use may be associated with cortical and subcortical structural abnormalities, vascular abnormalities, as well as neuropsychological decrements. Additionally, a battery of psychological tests are administered to provide information about demographics, drug use, neurocognitive measures, and personality structures....
Trial Details
| Field | Value |
|---|---|
| Start Date | 2006-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01034800
The ClinicalTrials.gov registry entry for NCT01034800 describes a study currently listed as completed, categorized as an unspecified phase. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Institute on Drug Abuse (NIDA), which has 335 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01034800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01034800 about?
NCT01034800 is a clinical study titled "The Neuropsychiatric Evaluation of HIV-Positive and Negative Drug Using Individuals: Study 215". The lack of success in treating substance abuse may be contributed to by a limited understanding of the clinical neurobiology of drug abuse. A better understanding of such deficits might aid in the development of more relevant pharmacological and psychosocial treatment approaches. Thus, the purpose ...
What is the current status of trial NCT01034800?
This trial is currently completed. The study started on 2006-09.
Who is sponsoring clinical trial NCT01034800?
This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.